Validity of galactin-3 in acromegaly: comparison with traditional markers.

Maryam Thaer SaadiNoor Ulhuda G MohammedBaydaa Ahmed AbedLayla Othman FarhanIsam Noori Salman

Published in: Irish journal of medical science (2024)

In a summary, this study recommended clinicians measure serum Gal-3 as biomarkers for patients with acromegaly. In addition, the result above shed light on role of Gal-3 on acromegaly pathogenesis and might provide a therapeutic target of acromegaly patients.

Keyphrases

end stage renal disease
growth hormone
ejection fraction
chronic kidney disease
newly diagnosed
peritoneal dialysis
prognostic factors
palliative care
patient reported